23 results
10-Q
szhrzznv5l 14fqz1t
10 May 21
Quarterly report
8:58am
10-Q
EX-10.1
2ui qxwjr30m6o4ax
10 May 21
Quarterly report
8:58am
424B5
hp58ewnq
21 Apr 21
Prospectus supplement for primary offering
4:45pm
424B5
1bsc2xop
19 Apr 21
Prospectus supplement for primary offering
4:57pm
S-3ASR
zfksndl
19 Apr 21
Automatic shelf registration
4:11pm
10-K
gnh3k zijtec0yeqf3x
1 Mar 21
Annual report
12:00am
424B5
aq2 ogo9r7b1chq
23 Sep 20
Prospectus supplement for primary offering
8:06am
424B5
wrogvvbw 53nvozhozj2
16 Sep 20
Prospectus supplement for primary offering
7:24am
6-K
EX-99.1
hwn0ev9o8wotm414
11 Sep 20
Zai Lab Limited Supplemental and Updated Disclosures
8:09am
6-K
EX-99.1
mk16jtuurbdpfr30
8 Apr 20
Zai Lab obtains rights to develop and exclusively commercialize REGN1979 in oncology in mainland China, Hong Kong, Taiwan and Macau
6:03am